Valentiner U, Knips J, Pries R, Clauditz T, Münscher A, Sauter G, et al. Selectin Binding Sites Are Involved in Cell Adhesive Properties of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2019;11: pubmed publisher

Grasso S, Chapelle J, Salemme V, Aramu S, Russo I, Vitale N, et al. The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries. Nat Commun. 2017;8:14797 pubmed publisher

Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher

Busch A, Bauer L, Wardelmann E, Rudack C, Grünewald I, Stenner M. Prognostic relevance of epithelial-mesenchymal transition and proliferation in surgically treated primary parotid gland cancer. J Clin Pathol. 2017;70:403-409 pubmed publisher

Zimmerlin L, Park T, Huo J, Verma K, Pather S, Talbot C, et al. Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development. 2016;143:4368-4380 pubmed

Wang R, Ma X, Li Y, He Y, Huang D, Cai S, et al. The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma. PLoS ONE. 2016;11:e0160527 pubmed publisher

Liu Y, Wang K, Xing H, Zhai X, Wang L, Wang W. Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers. Oncol Lett. 2016;12:1240-1256 pubmed

Virág J, Haberler C, Baksa G, Piurko V, Hegedûs Z, Reiniger L, et al. Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases. Pathol Oncol Res. 2017;23:245-252 pubmed publisher

Zhang H, Prado K, Zhang K, Peek E, Lee J, Wang X, et al. Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clin Cancer Res. 2016;22:5349-5361 pubmed

Giovannini C, Minguzzi M, Genovese F, Baglioni M, Gualandi A, Ravaioli M, et al. Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma. Oncotarget. 2016;7:39609-39626 pubmed publisher

Arévalo Turrubiarte M, Perruchot M, Finot L, Mayeur F, Dessauge F. Phenotypic and functional characterization of two bovine mammary epithelial cell lines in 2D and 3D models. Am J Physiol Cell Physiol. 2016;310:C348-56 pubmed publisher

Batchelder C, Martinez M, Tarantal A. Natural Scaffolds for Renal Differentiation of Human Embryonic Stem Cells for Kidney Tissue Engineering. PLoS ONE. 2015;10:e0143849 pubmed publisher

Zhang X, Jung I, Hwang Y. EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression. Tumour Biol. 2016;37:2555-63 pubmed publisher

Liew P, Hsu C, Liu W, Lee Y, Lee Y, Chen C. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma. Int J Clin Exp Pathol. 2015;8:5642-9 pubmed

Cheung S, Boey Y, Koh V, Thike A, Lim J, Iqbal J, et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:489-98 pubmed publisher

Wei X, Dou X, Bai J, Luo X, Qiu S, Xi D, et al. ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer. Oncotarget. 2015;6:21704-17 pubmed

Remo A, Simeone I, Pancione M, Parcesepe P, Finetti P, Cerulo L, et al. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer. J Transl Med. 2015;13:138 pubmed publisher

Brunner S, Weber F, Werner J, Agha A, Farkas S, Schlitt H, et al. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification. BMC Surg. 2015;15:49 pubmed publisher

Sanguinetti A, Santini D, Bonafè M, Taffurelli M, Avenia N. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment. World J Surg Oncol. 2015;13:129 pubmed publisher

Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed publisher

Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed publisher

Kap M, Lam K, Ewing Graham P, Riegman P. A reference image-based method for optimization of clinical immunohistochemistry. Histopathology. 2015;67:193-205 pubmed publisher

Gurzu S, Kádár Z, Sugimura H, Bara T, Hălmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-33 pubmed publisher

Calangiu C, Simionescu C, Stepan A, Cernea D, Zăvoi R, Mărgăritescu C. The expression of CK19, vimentin and E-cadherin in differentiated thyroid carcinomas. Rom J Morphol Embryol. 2014;55:919-25 pubmed

Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed

Kodama T, Motoi N, Ninomiya H, Sakamoto H, Kitada K, Tsukaguchi T, et al. A novel mechanism of EML4-ALK rearrangement mediated by chromothripsis in a patient-derived cell line. J Thorac Oncol. 2014;9:1638-46 pubmed publisher

Gwak J, Kim H, Kim E, Chung Y, Yun S, Seo A, et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat. 2014;147:39-49 pubmed publisher

Syed B, Green A, Nolan C, Morgan D, Ellis I, Cheung K. Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts. PLoS ONE. 2014;9:e100573 pubmed publisher

Miki Y, Hamada K, Yoshino T, Miyatani K, Takahashi K. Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma. Virchows Arch. 2014;464:725-34 pubmed publisher

Villarreal Calderon R, Luévano González A, Aragón Flores M, Zhu H, Yuan Y, Xiang Q, et al. Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis. Ann Diagn Pathol. 2014;18:129-35 pubmed publisher

Mato E, Gonzalez C, Moral A, Pérez J, Bell O, Lerma E, et al. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). J Mol Endocrinol. 2014;52:289-300 pubmed publisher

Jones H, Gold M, Giannico G, Troutman A, Vnencak Jones C, Schultenover S, et al. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014;33:64-73 pubmed publisher

Cañadas I, Rojo F, Taus A, Arpi O, Arumi Uria M, Pijuan L, et al. Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer. Clin Cancer Res. 2014;20:938-50 pubmed publisher

Chapelle J, Baudino A, Torelli F, Savino A, Morellato A, Angelini C, et al. The N-terminal domain of the adaptor protein p140Cap interacts with Tiam1 and controls Tiam1/Rac1 axis. Am J Cancer Res. 2020;10:4308-4324 pubmed

Niemeyer E, Mofid H, Zornig C, Burandt E, Stein A, Block A, et al. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family. BMC Gastroenterol. 2020;20:129 pubmed publisher

Li R, Zhong C, Yu Y, Liu H, Sakurai M, Yu L, et al. Generation of Blastocyst-like Structures from Mouse Embryonic and Adult Cell Cultures. Cell. 2019;179:687-702.e18 pubmed publisher

Narbe U, Sjöström M, Forsare C, Bendahl P, Alkner S, Leeb Lundberg L, et al. The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2019;175:305-316 pubmed publisher

Li Y, Hu Q, Li C, Liang K, Xiang Y, Hsiao H, et al. PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. J Clin Invest. 2019;129:1129-1151 pubmed publisher

Borcherding N, Cole K, Kluz P, Jorgensen M, Kolb R, Bellizzi A, et al. Re-Evaluating E-Cadherin and β-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast Cancer. Am J Pathol. 2018;188:1910-1920 pubmed publisher

Carreón Burciaga R, González González R, Molina Frechero N, López Verdin S, Pereira Prado V, Bologna Molina R. Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas. Anal Cell Pathol (Amst). 2018;2018:9392632 pubmed publisher

Liskova P, Dudakova L, Evans C, Rojas López K, Pontikos N, Athanasiou D, et al. Ectopic GRHL2 Expression Due to Non-coding Mutations Promotes Cell State Transition and Causes Posterior Polymorphous Corneal Dystrophy 4. Am J Hum Genet. 2018;102:447-459 pubmed publisher

Mishra P, Tang W, Putluri V, Dorsey T, Jin F, Wang F, et al. ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming. J Clin Invest. 2018;128:323-340 pubmed publisher

Maehara O, Suda G, Natsuizaka M, Ohnishi S, Komatsu Y, Sato F, et al. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma. Carcinogenesis. 2017;38:1073-1083 pubmed publisher

Noh M, Oh S, Ahn E, Kim Y, Jung T, Jung S, et al. Prognostic significance of E-cadherin and N-cadherin expression in Gliomas. BMC Cancer. 2017;17:583 pubmed publisher

Sommerova L, Ondrousková E, Vojtesek B, Hrstka R. Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition. BMC Cancer. 2017;17:546 pubmed publisher

Peters I, van der Steen M, Huisman B, Hilders C, Smit V, Vahrmeijer A, et al. Morphological and phenotypical features of ovarian metastases in breast cancer patients. BMC Cancer. 2017;17:206 pubmed publisher

Lefevre M, Rousseau A, Rayon T, Dalstein V, Clavel C, Beby Defaux A, et al. Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study. Br J Cancer. 2017;116:362-369 pubmed publisher

Ranieri D, Rosato B, Nanni M, Magenta A, Belleudi F, Torrisi M. Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition. Oncotarget. 2016;7:5440-60 pubmed publisher

Castro N, Fedorova Abrams N, Merchant A, Rangel M, Nagaoka T, Karasawa H, et al. Cripto-1 as a novel therapeutic target for triple negative breast cancer. Oncotarget. 2015;6:11910-29 pubmed

Miekus K, Pawlowska M, Sekuła M, Drabik G, Madeja Z, Adamek D, et al. MET receptor is a potential therapeutic target in high grade cervical cancer. Oncotarget. 2015;6:10086-101 pubmed

Nakamura M, Onoda N, Noda S, Kashiwagi S, Aomatsu N, Kurata K, et al. E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma. Mol Clin Oncol. 2014;2:226-232 pubmed

Mayer A, Hockel M, Schlischewsky N, Schmidberger H, Horn L, Vaupel P. Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix. Br J Cancer. 2013;108:402-8 pubmed publisher

Kroepil F, Fluegen G, Totikov Z, Baldus S, Vay C, Schauer M, et al. Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas. PLoS ONE. 2012;7:e46665 pubmed publisher

Bezdekova M, Brychtova S, Sedlakova E, Langova K, Brychta T, Belej K. Analysis of Snail-1, E-cadherin and claudin-1 expression in colorectal adenomas and carcinomas. Int J Mol Sci. 2012;13:1632-43 pubmed publisher